DIMENSIONAL FUND ADVISORS LP - SALIX PHARMACEUTICALS INC ownership

SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 357 filers reported holding SALIX PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 0.86 and the average weighting 0.4%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of SALIX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$18,657,000
+43.0%
107,970
-4.9%
0.01%
+33.3%
Q4 2014$13,049,000
-26.8%
113,516
-0.6%
0.01%
-30.8%
Q3 2014$17,838,000
+26.2%
114,174
-0.4%
0.01%
+30.0%
Q2 2014$14,137,000
+19.2%
114,613
+0.1%
0.01%
+11.1%
Q1 2014$11,864,000
+14.5%
114,508
-0.7%
0.01%
+12.5%
Q4 2013$10,365,000
+33.2%
115,262
-1.0%
0.01%
+14.3%
Q3 2013$7,783,000
+5.9%
116,385
+4.8%
0.01%0.0%
Q2 2013$7,348,000111,0830.01%
Other shareholders
SALIX PHARMACEUTICALS INC shareholders Q3 2014
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 300,000$46,872,00024.29%
HealthCor Management, L.P. 935,100$146,100,0007.50%
1492 Capital Management LLC 70,167$10,963,0006.07%
Visium Asset Management, LP 2,301,629$359,607,0005.31%
HWG Holdings LP 39,621$6,190,0004.97%
Riggs Asset Managment Co. Inc. 45,649$7,132,0004.14%
Cardinal Capital Management 49,139$7,677,0003.65%
AMI ASSET MANAGEMENT CORP 213,398$33,341,0003.27%
BENNETT LAWRENCE MANAGEMENT L L C/NY 88,435$13,817,0003.14%
Adamant Biomedical Investments AG 78,210$12,220,0003.05%
View complete list of SALIX PHARMACEUTICALS INC shareholders